Sacral neuromodulation outcomes for the treatment of refractory idiopathic detrusor overactivity stratified by indication: Lack of anticholinergic efficacy versus intolerability.

@article{Davis2013SacralNO,
  title={Sacral neuromodulation outcomes for the treatment of refractory idiopathic detrusor overactivity stratified by indication: Lack of anticholinergic efficacy versus intolerability.},
  author={Tanya Jane Davis and Iryna Makovey and Michael L Guralnick and R Corey O'connor},
  journal={Canadian Urological Association journal = Journal de l'Association des urologues du Canada},
  year={2013},
  volume={7 5-6},
  pages={176-8}
}
INTRODUCTION Patients may fail oral overactive bladder therapies due to either poor drug efficacy or intolerability. We determined if the success of sacral neuromodulation varies if performed secondary to lack of anticholinergic efficacy versus drug intolerability. METHODS A retrospective review was performed on 152 patients undergoing staged sacral neuromodulation from 2004 to 2010 for refractory idiopathic detrusor overactivity with or without urge incontinence. Outcomes following sacral… CONTINUE READING